The Netherlands: Levi’s wins trade mark claim against Hema

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The Netherlands: Levi’s wins trade mark claim against Hema

Denim giant Levi Strauss & Co has recently won a trade mark infringement case against Dutch retail chain Hema concerning its famous V-shaped stitching on the back pockets of its jeans.

The Arcuate mark

The dispute did not concern the word mark LEVI STRAUSS nor the characteristic red label flag (also known as The Red Tab), but covered the famous V-shaped stitching pattern also known as the Arcuate mark. The Arcuate pattern has been registered in the Benelux as a figurative mark since 1981. In addition, Levi Strauss is the holder of an EU figurative mark registered in 2004.

It is not the first time both brands have fought over the V-shaped stitching. In 2003 Levi's came across a variation of its Arcuate mark for the first time. The case was settled by both parties in 2004, when Hema recognised the exclusive trade mark rights of Levi's and declared that it would not use the Arcuate mark or a variation of the characteristic shape again. Hema seemed to comply with the agreement for a long period of time. However, in 2015 Levi's came across the use of a variation on its Arcuate mark again.

Non-identical signs

Along with its trade mark application, Levi's submitted a more detailed description of the sign, describing the mark as "the design of two curved lines positioned in the design of a pocket". The Brussels Commercial Court first established that in light of this description there were a number of differences which precluded the signs from being perceived as identical. Hema does not use two but three curved lines in the pattern. Moreover, the lines do not meet exactly in the centre but more on the left side of the pocket.

Visual similarity, identical goods and reputation

The Court held that that though the marks might not be identical, the marks do show significant similarity given the high degree of visual similarity, the fact that the signs are used for identical goods and that the Belgian public is very familiar with the mark. In the Court's view the stitching used by Hema creates a likelihood of confusion and therefore infringes the Arcuate mark.

Financial compensation

The Court prohibits Hema from further using the sign and orders a total of €4.5 million ($5 million) in damages, based on 221,603 sold articles across the Benelux. Initially Levi's had filed a damage claim of €50 ($60) per pair of jeans. The Court however, lowered this to a total of €20 ($24) for each pair sold in the Benelux since 2015, finding this a more reasonable and proportionate amount given the financial circumstances of the case. Hema has to pay a €100 ($118) fine for every pair of jeans sold after the ruling of May 14 with a maximum of €4 million ($5 million).

Myrthe Pardoen


V.O.Carnegieplein 5, 2517 KJThe HagueThe NetherlandsTel: +31 70 416 67 11Fax: +31 70 416 67 99info@vo.euwww.vo.eu

more from across site and SHARED ros bottom lb

More from across our site

Niri Shan, the newly appointed head of IP for UK, Ireland and the Middle East, explains why the firm’s international setup has brought UPC success, and addresses German partner departures
Vlad Stanese joins our ‘Five minutes with’ series to discuss potentially precedent-setting trademark and copyright cases and his love for aviation
Heath Hoglund, president of Via LA, discusses how it sets royalty rates and its plans to build on growth in China
Stobbs stands accused of interfering with the administration of justice after Brandsmiths’ client was subjected to an interim injunction for unjustified threats
The firm, known for its prosecution expertise, discusses its plans following the appointment of a UK-based patent litigation head and two new partners
Ed White at Clarivate provides an exclusive insight into the innovation power clusters reshaping Europe and the Middle East’s IP landscape, and why quality is the new currency of invention
In the first in a new podcast series celebrating the tenth anniversary of IP Inclusive, we look back at the network’s origins and discuss its mission
Rebecca Schwarz at Haynes Boone shares how her team secured victory for biopharma client RedHill in a licensing dispute involving a developmental cancer drug
News of a breakaway firm launching in Germany and a spike in vaccine-related patent applications were also among the top talking points
A flurry of hiring activity among UK firms suggests they are confident of mounting a serious challenge at the UPC
Gift this article